期刊文献+

某院新生儿科预防性抗真菌药物应用分析 被引量:2

Application of prophylactic antifungal agents in neonatal department
下载PDF
导出
摘要 目的探讨我院新生儿科预防性抗真菌药物应用情况,为优化新生儿科预防真菌感染的管理模式及临床合理用药提供参考。方法统计分析我院2017-2020年新生儿科收治的53例预防性应用抗真菌药物的新生儿,记录预防用药的指征、品种、剂量、疗程等。结果53例预防性应用抗真菌药物治疗的新生儿中,预防用药指征为早产儿、低出生体重、较长住院时间、长期胃肠外营养、长期使用广谱抗菌药物,预防性应用抗真菌药物为氟康唑,剂量3 mg/(kg·d),q72h,预防用药疗程1~5周,预防期间并未发现抗真菌药物相关不良反应。结论氟康唑用于预防性新生儿真菌感染安全有效,对合并2个以上真菌感染高危因素患者,建议经验性启用预防抗真菌药物治疗,疗程不超过4周。 Objective To investigate the application of prophylactic antifungal agents in neonatal department of our hospital,and to provide reference for clinical rational drug use and explore a better management mode of preventing fungal infection in neonatal department.Methods A total of 53 newborns with prophylactic antifungal agents in our hospital from 2017 to 2020 were investigated,and the indications,varieties,dosage and course of prophylactic drugs were analyzed.Results The indications of prophylactic antifungal agents were premature infants,low birth weight,long hospital stay,long-term intravenous nutrition and long-term use of broad-spectrum antibiotics.The prophylactic antifungal agents were fluconazole 3 mg/(kg·d),q72h,1~5 weeks.No adverse reactions related to antifungal drugs were found during prevention.Conclusion Fluconazole is effective and safe for the prevention of neonatal fungal infection.For the combination of more than two high-risk factors of fungal infection,it is recommended to empirically use preventive antifungal drugs,and the course of treatment should not exceed 4 weeks.
作者 吴劲东 吴少梅 植自勤 WU Jin-dong;WU Shao-mei;ZHI Zi-qin(Foshan Sanshui Maternal and Child Health Hospital,Foshan 528100,China)
出处 《实用药物与临床》 CAS 2022年第7期618-621,共4页 Practical Pharmacy and Clinical Remedies
关键词 新生儿 真菌感染 预防用药 Neonate Fungal infection Prophylaxic drug use
  • 相关文献

参考文献8

二级参考文献72

  • 1López Sastre JB,Coto Cotallo GD,Fernández Colomer B.Neonatal invasive candidiasis:a prospective multicenter study of 118 cases[J].Am J Perinatol,2003,20(3):153-163.
  • 2Dassonville C,Demattei C,Detaint B,et al.Assessment and predictors determination of indoor airborne fungal concentrations in Paris newborn babies'homes[J].Environ Res,2008,108(1):80-85.
  • 3Arslankoylu AE,Kuyucu N,Yilmaz BS,et al.Symptomatic and asymptomatic candidiasis in a pediatric intensive care unit[J].Ital J Pediatr,2011,3(37):56.
  • 4Burwell LA, Kaufman D, Blakely J, et al. Antifungal prophy- laxis to prevent neonatal candidiasis: a survey of perinatal physician practices [ J ]. Pediatr, 2006,118 ( 4 ) : el 019 -el 025.
  • 5Mersal A, Alzahrani I, Azzouz M, et al. Oral nystatin versus in-travenous fluconazole as neonatal antifungal prophylaxis:non- inferiority trial[ J]. J Clin Neonatology,2013,2(2) :88-92.
  • 6Aydemir C, Oguz SS, Dizdar EA, et al. Randomised controlled trial of prophylactic fluconazole versus nystatin for the preven- tion of fungal colonisation and invasive fungal infection in very low birth weight infants [ J ]. Arch Dis Child Fetal Neo- natal Ed,2011,96 ( 3 ) : F164-F168.
  • 7Parikh TB, Nanavati RN, Patankar CV, et al. Fluconazole prophylaxis against fungal colonization and invasive fungal in- fection in very low birth weight infants[J]. Indian Pediatr, 2007,44( 11 ) :830-837.
  • 8Kathia R, Teresa MM, Manuel E, et al. Impact of routine flu- conazole prophylaxis for premature infants with birth weights of less than 1250 grams in a developing country [J]. Pediatr Infec Dis Journal,2010,29( 11 ) :1050-1052.
  • 9Weitkamp JH, Ozdas A, LaFleur B, et al. Fluconazole prophy- laxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure[ J]. J Perina- tology, 2008,28 ( 6 ) :405-411.
  • 10Healy CM, Campbell JR, Zaccafia E, et al. fluconazole prophy- laxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole- resistant candida species [ J ]. Pediatr,2008,121 (4) :703-710.

共引文献30

同被引文献20

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部